| Cherie Wagahoft, ANP-BC | |
|
3340 Providence Dr Ste 452, Anchorage, AK 99508-4628 | |
| (907) 562-2120 | |
| (907) 562-6527 |
| Full Name | Cherie Wagahoft |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 3340 Providence Dr Ste 452, Anchorage, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497015838 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 1290 (Alaska) | Primary |
| Entity Name | Alaska Native Tribal Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
A new evidence-based map estimates that in 2009 2.85 billion people lived "at risk of infection" with the malaria parasite Plasmodium vivax, BMJ News reports. As described in a study, published Tuesday in PLoS Neglected Tropical Diseases, P vivax "is more widespread and potentially represents a greater burden on human health in some parts of the world than P falciparum, the species usually associated with the greatest mortality and morbidity," BMJ News writes (Moszynski, 8/3).
In response to an article examining USAID's prospects, Senator Richard Lugar (R-Ind.) writes in a Washington Post letter to the editor that the agency's "institutional atrophy and loss of expertise" has resulted in a "proliferation of aid programs across the government with little coordination or a common framework to evaluate what works and what doesn't."
Anadys Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of chronic hepatitis C virus (HCV) infection. ANA598 is Anadys' investigational hepatitis C non-nucleoside polymerase inhibitor.
Indian pharmaceutical companies Cipla and Ranbaxy under an agreement with the Clinton Foundation will reduce the prices of 19 different pediatric antiretroviral drugs in 62 developing countries to an average of 45% less than what treatments currently cost in the countries, former President Clinton announced on Thursday ahead of World AIDS Day on Dec. 1, the AP/Forbes reports.
› Verified 9 days ago
| Entity Name | Southcentral Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780614263 PECOS PAC ID: 5496663627 Enrollment ID: O20051027000416 |
News Archive
A new evidence-based map estimates that in 2009 2.85 billion people lived "at risk of infection" with the malaria parasite Plasmodium vivax, BMJ News reports. As described in a study, published Tuesday in PLoS Neglected Tropical Diseases, P vivax "is more widespread and potentially represents a greater burden on human health in some parts of the world than P falciparum, the species usually associated with the greatest mortality and morbidity," BMJ News writes (Moszynski, 8/3).
In response to an article examining USAID's prospects, Senator Richard Lugar (R-Ind.) writes in a Washington Post letter to the editor that the agency's "institutional atrophy and loss of expertise" has resulted in a "proliferation of aid programs across the government with little coordination or a common framework to evaluate what works and what doesn't."
Anadys Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of chronic hepatitis C virus (HCV) infection. ANA598 is Anadys' investigational hepatitis C non-nucleoside polymerase inhibitor.
Indian pharmaceutical companies Cipla and Ranbaxy under an agreement with the Clinton Foundation will reduce the prices of 19 different pediatric antiretroviral drugs in 62 developing countries to an average of 45% less than what treatments currently cost in the countries, former President Clinton announced on Thursday ahead of World AIDS Day on Dec. 1, the AP/Forbes reports.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cherie Wagahoft, ANP-BC 3340 Providence Dr Ste 452, Anchorage, AK 99508-4628 Ph: (907) 562-2120 | Cherie Wagahoft, ANP-BC 3340 Providence Dr Ste 452, Anchorage, AK 99508-4628 Ph: (907) 562-2120 |
News Archive
A new evidence-based map estimates that in 2009 2.85 billion people lived "at risk of infection" with the malaria parasite Plasmodium vivax, BMJ News reports. As described in a study, published Tuesday in PLoS Neglected Tropical Diseases, P vivax "is more widespread and potentially represents a greater burden on human health in some parts of the world than P falciparum, the species usually associated with the greatest mortality and morbidity," BMJ News writes (Moszynski, 8/3).
In response to an article examining USAID's prospects, Senator Richard Lugar (R-Ind.) writes in a Washington Post letter to the editor that the agency's "institutional atrophy and loss of expertise" has resulted in a "proliferation of aid programs across the government with little coordination or a common framework to evaluate what works and what doesn't."
Anadys Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of chronic hepatitis C virus (HCV) infection. ANA598 is Anadys' investigational hepatitis C non-nucleoside polymerase inhibitor.
Indian pharmaceutical companies Cipla and Ranbaxy under an agreement with the Clinton Foundation will reduce the prices of 19 different pediatric antiretroviral drugs in 62 developing countries to an average of 45% less than what treatments currently cost in the countries, former President Clinton announced on Thursday ahead of World AIDS Day on Dec. 1, the AP/Forbes reports.
› Verified 9 days ago
Ms. Mary Kay Mccarty, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3925 Tudor Centre Dr, #100, Anchorage, AK 99508 Phone: 907-561-8301 Fax: 907-561-8170 | |
Mindy Lorin Schloss, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6852 Cutty Sark St, Anchorage, AK 99502 Phone: 907-243-5936 | |
Katherine L Sterner, A.N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4201 Tudor Centre Dr, Suite 320, Anchorage, AK 99508 Phone: 907-729-4955 | |
Sandra Frenier, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3340 Providence Dr, Suite 452, Anchorage, AK 99508 Phone: 907-562-2120 | |
Janet A Bloch, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3851 Piper St, U340, Anchorage, AK 99508 Phone: 907-562-0321 Fax: 907-562-2683 | |
Lois A Rockcastle, ANP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3801 University Lake Dr Ste 205, Anchorage, AK 99508 Phone: 907-563-1600 Fax: 907-563-0100 | |
Mrs. Megan Renee Hathcoat, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1200 Airport Heights Dr Ste 200, Anchorage, AK 99508 Phone: 907-262-4278 |